4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-042222
President sold 15,275 shares at $49.00 ($748,475)
- President acquired 15,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-07-09 | Option exercise | +15,275 | $0.84 | $12,831 | 15,275 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2020-07-09 | Sale | −15,275 | $49.00 | $748,475 | 0 | D: show line 2 in the form |
| Open-market sales · 15,275 sh · avg $49.00 · $748,475 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-07-09 | Option exercise · Stock Option (Right to Buy) | −15,275 | 94,725 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…